Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer

BACKGROUND: Several studies have shown the advantage of delayed-time-point imaging with 18F-FDG-PET/CT to distinguish malignant from benign uptake. This may be relevant in cancer diseases with low metabolism, such as breast cancer. We aimed at examining the change in SUV from 1 h (1h) to 3 h (3h) ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Baun, Christina, Falch, Kirsten, Gerke, Oke, Hansen, Jeanette, Nguyen, Tram, Alavi, Abass, Høilund-Carlsen, Poul-Flemming, Hildebrandt, Malene G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943993/
https://www.ncbi.nlm.nih.gov/pubmed/29743027
http://dx.doi.org/10.1186/s12880-018-0254-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943993/
https://www.ncbi.nlm.nih.gov/pubmed/29743027
http://dx.doi.org/10.1186/s12880-018-0254-8

Ejemplares similares